Sphingolipid-neutralizing molecular therapy reduces psychosine cytotoxicity in Krabbe disease

ABSTRACT:

SUBMITTER: Begum S 

PROVIDER: S-EPMC12930047 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature